000 | 01506 a2200409 4500 | ||
---|---|---|---|
005 | 20250517111927.0 | ||
264 | 0 | _c20170830 | |
008 | 201708s 0 0 eng d | ||
022 | _a1878-4216 | ||
024 | 7 |
_a10.1016/j.pnpbp.2016.08.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFernandes, C E M | |
245 | 0 | 0 |
_aCholinergic agonist reverses H1-induced memory deficit in mice. _h[electronic resource] |
260 |
_bProgress in neuro-psychopharmacology & biological psychiatry _c01 2017 |
||
300 |
_a16-22 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmygdala _xdrug effects |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzamides _xtherapeutic use |
650 | 0 | 4 |
_aBridged Bicyclo Compounds _xtherapeutic use |
650 | 0 | 4 |
_aChlorpheniramine _xtoxicity |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aHistamine H1 Antagonists _xtoxicity |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMaze Learning _xdrug effects |
650 | 0 | 4 |
_aMemory Disorders _xchemically induced |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMicroinjections |
650 | 0 | 4 |
_aNicotinic Agonists _xtherapeutic use |
700 | 1 | _aSerafim, K R | |
700 | 1 | _aGianlorenço, A C L | |
700 | 1 | _aMattioli, R | |
773 | 0 |
_tProgress in neuro-psychopharmacology & biological psychiatry _gvol. 72 _gp. 16-22 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pnpbp.2016.08.007 _zAvailable from publisher's website |
999 |
_c26331353 _d26331353 |